Ball, B., Strickland, S., Morrison, B., DiPersio, J., Kushwaha, S., Lee, B., Ghiraldi, R., Cho, K., Goll, J., Sallman, D., Issa, G. (2025). A first-in-human phase 1 Study of cbx-250, a TCR-mimetic bispecific T cell engager targeting CG1/ HLA-a*02:01 in patients with relapsed or refractory AML, HR-MDS, or CMML (CROSSCHECK-001) (Trial in Progress). Blood. https://doi.org/10.1182/blood-2025-3430